Inovio Pharmaceuticals Reports 2019 First Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Oil settles up over $2 as Iran war stalemate stokes supply concerns
- L3Harris CEO steps down amid conduct review, shares drop
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
Inovio Pharma (INO) Reports Q1 Loss of $0.30/Share
May 9, 2019 4:48 PM EDTInovio Pharma (NASDAQ: INO) reported Q1 EPS of ($0.30), versus ($0.36) reported last year. Revenue for the quarter came in at $2.83 million, versus $1.53 million reported last year.
For earnings history and earnings-related data on Inovio Pharma (INO) click here.
... More